Novo Holdings, an international life science investor, announced a £50 million investment in Oxford Nanopore Technologies, a UK Listed company behind a new generation of molecular sensing technology based on nanopores.   Oxford Nanopore has developed a new generation of molecular analysis technology used for DNA/RNA sequencing. The technology is designed to offer rich data including epigenetics, rapid insights through real-time workflows and portable formats, in a way that is accessible and af...